Skip to main content

Brookfield Renewable Announces Dividend Rates On Its Series 1 and Series 2 Preference Shares

All amounts in Canadian dollars unless otherwise stated BROOKFIELD, News, April 01, 2025 (GLOBE NEWSWIRE) — Brookfield Renewable Partners L.P. (NYSE: BEP; TSX: BEP.UN) (“Brookfield Renewable”) today announced that Brookfield Renewable Power Preferred Equity Inc. (“BRP Equity”) has determined the fixed dividend rate on its Class A Preference Shares, Series 1 (“Series 1 Shares”) (TSX:BRF.PR.A) for the five years commencing May 1, 2025 and ending April 30, 2030 and the floating dividend rate on its Class A Preference Shares, Series 2 (“Series 2 Shares”) (TSX: BRF.PR.B) for the quarterly dividend payable on July 31, 2025. Series 1 Shares If declared, the fixed quarterly dividends on the Series 1 Shares during that period will be paid at an annual rate of 5.203% ($0.3251875 per share per quarter). Holders of Series 1 Shares have the...

Continue reading

Jamf completes acquisition of Identity Automation, expanding its platform to include dynamic identity management for specific industries

MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) — Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, today announced it has completed the acquisition of Identity Automation, a dynamic identity and access management (IAM) platform for industries that are defined by frequent role adjustments, such as education and healthcare. By acquiring Identity Automation, Jamf gains almost 90 employees, as well as a key product differentiator: dynamic identity management. In K-12 education and other mobile device-centric industries, roles and access constantly shift. Identity Automation’s platform dynamically adjusts access, device, and security policies in real time based on schedules, locations, and role changes. Through integrations with ecosystem partners and Jamf, a best-in-class device login and user experience is achieved. Jamf...

Continue reading

Sportsman’s Warehouse Holdings, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results

Q4 same store sales of -0.5% on comparable 13-week basis, versus -12.8% in Q4 last yearQ4 Adj EBITDA of $14.6 million versus $5.3 million in Q4 last year; reduced net debt by $27.3 million versus end of last yearInventory decreased $12.8 million versus end of last year; ended FY2024 with liquidity of $131.1 millionSignificantly outperformed the Q4 adjusted NICS dataExpects positive same store sales in 2025 WEST JORDAN, Utah, April 01, 2025 (GLOBE NEWSWIRE) — Sportsman’s Warehouse Holdings, Inc. (“Sportsman’s Warehouse” or the “Company”) (Nasdaq: SPWH) today announced financial results for the thirteen and fifty-two weeks ended February 1, 2025. “We were pleased that our quarterly trends continued to improve, with same store sales down slightly at 0.5% in the fourth quarter on a year-over-year comparable 13-week basis,”...

Continue reading

Diamondback Energy, Inc. Announces Closing of Double Eagle Acquisition

MIDLAND, Texas, April 01, 2025 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback” or “the Company”) today announced that it has completed its previously announced acquisition of certain subsidiaries of Double Eagle IV Midco, LLC (“Double Eagle”). About Diamondback Diamondback is an independent oil and natural gas company headquartered in Midland, Texas focused on the acquisition, development, exploration and exploitation of unconventional, onshore oil and natural gas reserves in the Permian Basin in West Texas. For more information, please visit www.diamondbackenergy.com. Forward-Looking Statements This news release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, which involve risks, uncertainties, and assumptions. All statements,...

Continue reading

Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma

MELBOURNE, Australia, April 02, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX; NASDAQ: TLX, Telix, the Company) today announces that a first patient has been dosed in the Phase 1 ZOLAR1 trial of TLX300-CDx (89Zr-olaratumab) in patients with advanced, metastatic soft tissue sarcoma (STS) at the Melbourne Theranostic Innovation Centre (MTIC) in Melbourne, Australia. ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical targeting platform. Olaratumab targets platelet-derived growth factor receptor alpha (PDGFRα) a cell surface protein often over-expressed in STS. The aim of the trial is to evaluate the safety, pharmacokinetics, biodistribution and dosimetry, and establish...

Continue reading

Nokia Corporation: Repurchase of own shares on 01.04.2025

Nokia CorporationStock Exchange Release1 April 2025 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 01.04.2025 Espoo, Finland – On 1 April 2025 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:                Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 2,069,501 4.99CEUX 1,600,000 4.99BATE – –AQEU 146,720 4.99TQEX 126,006 4.99Total 3,942,227 4.99* Rounded to two decimals On 22 November 2024, Nokia announced that its Board of Directors is initiating a share buyback program to offset the dilutive effect of new Nokia shares issued to the shareholders of Infinera Corporation and certain Infinera Corporation share-based incentives. The repurchases in compliance with the Market Abuse Regulation (EU)...

Continue reading

LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference

BURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 3:45 PM EDT. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com. CONTACT: Contact: Sandra Millar LeMaitre Vascular, Inc. +1-781-425-1686 smillar@lemaitre.com

Continue reading

Stallion Uranium Announces C$1.2 Million Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to announce a non-brokered private placement of up to 13,000,000 common shares (the “Shares”) at a price of CDN$0.10 per Share for gross proceeds of up to CDN$1,300,000 (the “Offering”). Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 – Prospectus Exemptions (“NI 45-106”), up to 12,000,000 Shares (the “LIFE Securities”) will be offered pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the “Listed Issuer Financing Exemption”). The Shares issued issuable pursuant to the sale of the LIFE...

Continue reading

First Bank Announces First Quarter 2025 Earnings Conference Call

HAMILTON, N.J., April 01, 2025 (GLOBE NEWSWIRE) — First Bank (Nasdaq Global Market: FRBA) invites participation in a conference call to discuss the Company’s financial and operating performance during its first quarter ending on March 31, 2025.Event: Earnings Conference Call – First Quarter 2025   When: Wednesday, April 23, 2025 at 9:00 a.m. Eastern Time   Access: Conference Call Dial-In:             (800) 715-9871  (toll free)     Conference Call Access Code:  3909613   Patrick L. Ryan, President and Chief Executive Officer, Andrew L. Hibshman, Chief Financial Officer, Peter J. Cahill, Chief Lending Officer, and Darleen Gillespie, Chief Retail Banking Officer will provide an overview of first quarter 2025 results. The management presentation typically lasts approximately fifteen to thirty minutes, followed...

Continue reading

Winnebago Industries Announces “Hit It To Win It” Sweepstakes, Return of “The Dock” for 2025 Minnesota Twins Season

Leading outdoor recreation product manufacturer begins second season as the ‘Official Outdoor Adventure Partner’ of the Twins EDEN PRAIRIE, Minn., April 01, 2025 (GLOBE NEWSWIRE) — With the Minnesota Twins Home Opener just around the corner, Winnebago Industries (NYSE: WGO), a leading manufacturer of outdoor recreation products, and ‘Official Outdoor Adventure Partner’ of the Twins, today announced the launch of the “Hit It To Win It” sweepstakes, where a fan could win an RV or boat from Winnebago Industries’ portfolio of premium brands. “Winnebago Industries is excited to again partner with the Minnesota Twins to bring our shared passion for the outdoors to fans at Target Field and across Twins Territory,” said Amber Holm, Winnebago Industries’ Chief Marketing Officer. “The “Hit it To Win It” sweepstakes offers fans a chance to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.